Alibaba Health Information Technology Ltd (ALBBY)
8.62
0.00 (0.00%)
USD |
OTCM |
Jun 21, 16:00
Alibaba Health Information Technology Total Assets (Quarterly): 2.938B for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 2.938B |
| September 30, 2023 | 2.938B |
| March 31, 2023 | 3.015B |
| September 30, 2022 | 2.852B |
| September 30, 2022 | 2.852B |
| March 31, 2022 | 3.020B |
| September 30, 2021 | 3.038B |
| September 30, 2021 | 3.038B |
| March 31, 2021 | 2.695B |
| September 30, 2020 | 2.516B |
| September 30, 2020 | 2.516B |
| March 31, 2020 | 1.107B |
| September 30, 2019 | 1.125B |
| September 30, 2019 | 1.125B |
| March 31, 2019 | 891.06M |
| September 30, 2018 | 796.72M |
| September 30, 2018 | 796.72M |
| March 31, 2018 | 494.83M |
| September 30, 2017 | 280.39M |
| September 30, 2017 | 280.39M |
| Date | Value |
|---|---|
| March 31, 2017 | 243.77M |
| September 30, 2016 | 226.14M |
| September 30, 2016 | 226.14M |
| March 31, 2016 | 208.48M |
| September 30, 2015 | 217.80M |
| September 30, 2015 | 217.80M |
| March 31, 2015 | 226.90M |
| September 30, 2014 | 232.91M |
| September 30, 2014 | 232.91M |
| March 31, 2014 | 63.71M |
| September 30, 2013 | 49.03M |
| September 30, 2013 | 49.03M |
| March 31, 2013 | 51.51M |
| September 30, 2012 | 70.08M |
| March 31, 2012 | 67.84M |
| September 30, 2011 | 68.79M |
| March 31, 2011 | 72.68M |
| September 30, 2010 | 71.90M |
| March 31, 2010 | 73.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.107B
Minimum
Mar 2020
3.038B
Maximum
Sep 2021
2.484B
Average
2.852B
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 58.01M |
| Zai Lab Ltd | 988.44M |
| Adagene Inc | 115.73M |
| LakeShore Biopharma Co Ltd | 220.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 737.09M |
| Shareholders Equity (Quarterly) | 2.205B |
| Current Ratio | 3.01 |